RGBiotech Logo  
Find Products & Services By Categories.
Search




Home -> Support -> Applications -> Cre-Dependent GluN2B Knockdown Tool for Precision Neural Research
 
Quick Inquiry  

Cre-Dependent GluN2B Knockdown Tool for Precision Neural Research

RGBiotech offers pAAV-CMV-dsRed-pSico-GFP-GluN2BshRNA plasmid vector - a state-of-the-art tool designed for Cre-dependent knockdown of mouse GluN2B. This plasmid vector utilizes AAV expression vector backbone that allows further production of high titers of Adeno-associated viruses (AAV) particles with serotype of interest. Please contact us at admin@rgbiotech.com for pricing and more information.

How It Works?

The AAV1-CMV-dsRed-pSico-GluN2BshRNA plasmid incorporates a sophisticated dual-fluorescence reporter system (dsRed and GFP) that provides real-time, visual validation of two critical experimental milestones: successful transduction and Cre-mediated induction of mouse GluN2B shRNA expression.
The dsRed fluorescent protein is expressed constitutively under the control of the CMV promoter, independent of Cre recombination. Its persistent expression allows for straightforward quantification of transfection efficiency in vitro or transduction efficiency in vivo following AAV delivery. The bright, stable dsRed signal enables researchers to accurately identify and confirm which cells or tissue regions have received the vector, ensuring robust and interpretable experimental results.
The GFP reporter gene is positioned within the loxP-flanked "STOP" cassette that silences the U6-shRNA expression module. In its default state (pre-recombination), cells expressing dsRed will also express GFP, resulting in a dual-fluorescent population. Upon delivery of Cre recombinase, the excision of this STOP cassette simultaneously activates the transcription of the mouse GluN2B-specific shRNA and permanently disrupts the GFP reporter gene. Consequently, the loss of GFP fluorescence serves as a direct and intuitive visual indicator of successful Cre-mediated recombination and, by extension, the active expression of the GluN2B-targeting shRNA.

Advantages

1) High Specificity: shRNA expression restricted to Cre-positive cells.
2) Visual Confirmation: Dual fluorescence for easy monitoring of infection and recombination.
3) Flexibility: Compatible with in vitro, ex vivo, and in vivo models.
4) Validated in Peer-Reviewed Studies.

Applications

The AAV-CMV-dsRed-pSicoGluN2BshRNA vector is a versatile tool for diverse research areas, including:
1) Synaptic Plasticity: Investigating GluN2B’s role in LTP, long-term depression (LTD), and synapse formation in specific brain regions
2) Cognitive Neuroscience: Studying memory and learning deficits via region-specific GluN2B knockdown (e.g., hippocampus, prefrontal cortex)
3) Neurodegenerative Diseases: Evaluating GluN2B as a therapeutic target in Alzheimer’s, Parkinson’s, and Huntington’s disease models
4) Neurodevelopment: Assessing GluN2B’s function in neural progenitor cell differentiation and circuit formation
5) Psychiatric Disorders: Modeling schizophrenia and depression by modulating GluN2B levels in reward-related brain regions

Frequently Asked Questions (FAQs)

Q1: How do I confirm GluN2B knockdown efficiency?
A1: We recommend combining fluorescence imaging (GFP/dsRed) with molecular validation: qRT-PCR for GluN2B mRNA levels and Western blot for protein expression.

Q2: Can this vector be used in non-neuronal cells?
A2: Yes-while GluN2B is most abundant in neurons, it is also expressed in astrocytes and microglia.

Q3: Is the vector suitable for in vivo studies?
A3: Absolutely. This plasmid vector can be packaged into AAV particles which are ideal for in vivo use due to their low immunogenicity and long-term transgene expression.

Read More

The mouse GluN2B gene (also known as Grin2b), encoding the GluN2B subunit of N-methyl-D-aspartate receptors (NMDARs), stands as a pivotal regulator of synaptic development, plasticity, and cognitive function. As a core component of NMDARs, GluN2B is predominantly expressed in the hippocampus, cortex, and other brain regions critical for learning and memory formation. Its unique kinetic properties-including prolonged channel opening and high calcium permeability-enable it to mediate long-term potentiation (LTP), the cellular basis of memory, and synapse maturation.
Elevated GluN2B levels in the forebrain have been linked to enhanced synaptic plasticity but also increased neuronal excitotoxicity. In rodent models, targeted GluN2B overexpression leads to improved spatial memory but heightened susceptibility to seizure activity and neuroinflammatory responses. Selective GluN2B knockdown provides invaluable insights into its tissue-specific roles-overcoming the neonatal lethality of global GluN2B knockout models. Studies show that hippocampal GluN2B depletion impairs LTP in CA3 synapses, disrupts postsynaptic macromolecular organization, and results in deficits in contextual fear memory. In therapeutic research, GluN2B knockdown has demonstrated potential in mitigating neuroinflammation in Alzheimer’s disease and traumatic brain injury models.

 

Products & Services
Resources
     
 
  Home
Products & Services
Support
About Us
Contact Us
Promotions
Flyers
Brochures
Publications
News & Events
Terms & Conditions
Privacy
Disclaimers

Contact Us

EMAIL: admin@rgbiotech.com
 
 
© RGBiotech All Rights Reserved.